 | • レポートコード：QY2207C3493 • 出版社/出版日：QYResearch / 2022年7月11日 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界のDOA（薬物乱用）リーダーの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にDOA（薬物乱用）リーダーの世界市場のxxx％を占める「手持ち型DOAリーダー」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のDOA（薬物乱用）リーダーの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのDOA（薬物乱用）リーダー市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのDOA（薬物乱用）リーダー市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 DOA（薬物乱用）リーダーのグローバル主要メーカーには、Prometheus、T-READER、DIALAB、Princeton BioMeditech、Abbott、Zhejiang Orient Gene Biotech、Assure Tech (Hangzhou)、Wuhan NanoDiagnosis For Health Biotechnology、Simple & Smart Instrument (Nanjing)、Xuzhou Anding Biotechnology、Guangdong Jindun Electronic Technologyなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 DOA（薬物乱用）リーダー市場は、種類と用途によって区分されます。世界のDOA（薬物乱用）リーダー市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 手持ち型DOAリーダー、卓上型DOAリーダー 【用途別セグメント】 病院、研究所、防衛安全保障、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - DOA（薬物乱用）リーダー製品概要 - 種類別市場（手持ち型DOAリーダー、卓上型DOAリーダー） - 用途別市場（病院、研究所、防衛安全保障、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のDOA（薬物乱用）リーダー販売量予測2017-2028 - 世界のDOA（薬物乱用）リーダー売上予測2017-2028 - DOA（薬物乱用）リーダーの地域別販売量 - DOA（薬物乱用）リーダーの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別DOA（薬物乱用）リーダー販売量 - 主要メーカー別DOA（薬物乱用）リーダー売上 - 主要メーカー別DOA（薬物乱用）リーダー価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（手持ち型DOAリーダー、卓上型DOAリーダー） - DOA（薬物乱用）リーダーの種類別販売量 - DOA（薬物乱用）リーダーの種類別売上 - DOA（薬物乱用）リーダーの種類別価格 ・用途別市場規模（病院、研究所、防衛安全保障、その他） - DOA（薬物乱用）リーダーの用途別販売量 - DOA（薬物乱用）リーダーの用途別売上 - DOA（薬物乱用）リーダーの用途別価格 ・北米市場 - 北米のDOA（薬物乱用）リーダー市場規模（種類別、用途別） - 主要国別のDOA（薬物乱用）リーダー市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのDOA（薬物乱用）リーダー市場規模（種類別、用途別） - 主要国別のDOA（薬物乱用）リーダー市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のDOA（薬物乱用）リーダー市場規模（種類別、用途別） - 主要国別のDOA（薬物乱用）リーダー市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のDOA（薬物乱用）リーダー市場規模（種類別、用途別） - 主要国別のDOA（薬物乱用）リーダー市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのDOA（薬物乱用）リーダー市場規模（種類別、用途別） - 主要国別のDOA（薬物乱用）リーダー市場規模（トルコ、サウジアラビア） ・企業情報 Prometheus、T-READER、DIALAB、Princeton BioMeditech、Abbott、Zhejiang Orient Gene Biotech、Assure Tech (Hangzhou)、Wuhan NanoDiagnosis For Health Biotechnology、Simple & Smart Instrument (Nanjing)、Xuzhou Anding Biotechnology、Guangdong Jindun Electronic Technology ・産業チェーン及び販売チャネル分析 - DOA（薬物乱用）リーダーの産業チェーン分析 - DOA（薬物乱用）リーダーの原材料 - DOA（薬物乱用）リーダーの生産プロセス - DOA（薬物乱用）リーダーの販売及びマーケティング - DOA（薬物乱用）リーダーの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - DOA（薬物乱用）リーダーの産業動向 - DOA（薬物乱用）リーダーのマーケットドライバー - DOA（薬物乱用）リーダーの課題 - DOA（薬物乱用）リーダーの阻害要因 ・主な調査結果 |
The DOA reader is designed to qualitatively measure drugs of abuse from urine, saliva, or whole blood samples. The system is intended for use in in vitro diagnostics as an aid in monitoring the effectiveness of drugs of abuse. It must be used by the relevant personnel together with the corresponding drug test strips.
Market Analysis and Insights: Global DOA (Drug of Abuse) Readers Market
Due to the COVID-19 pandemic, the global DOA (Drug of Abuse) Readers market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Handheld DOA Reader accounting for % of the DOA (Drug of Abuse) Readers global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China DOA (Drug of Abuse) Readers market size is valued at US$ million in 2021, while the US and Europe DOA (Drug of Abuse) Readers are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe DOA (Drug of Abuse) Readers landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of DOA (Drug of Abuse) Readers include Prometheus, T-READER, DIALAB, Princeton BioMeditech, Abbott, Zhejiang Orient Gene Biotech, Assure Tech (Hangzhou), Wuhan NanoDiagnosis For Health Biotechnology and Simple & Smart Instrument (Nanjing), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global DOA (Drug of Abuse) Readers Scope and Segment
DOA (Drug of Abuse) Readers market is segmented by Type and by Application. Players, stakeholders, and other participants in the global DOA (Drug of Abuse) Readers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Handheld DOA Reader
Desktop DOA Reader
Segment by Application
Hospitals
Laboratories
Defense Security
Others
By Company
Prometheus
T-READER
DIALAB
Princeton BioMeditech
Abbott
Zhejiang Orient Gene Biotech
Assure Tech (Hangzhou)
Wuhan NanoDiagnosis For Health Biotechnology
Simple & Smart Instrument (Nanjing)
Xuzhou Anding Biotechnology
Guangdong Jindun Electronic Technology
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 DOA (Drug of Abuse) Readers Product Introduction
1.2 Market by Type
1.2.1 Global DOA (Drug of Abuse) Readers Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Handheld DOA Reader
1.2.3 Desktop DOA Reader
1.3 Market by Application
1.3.1 Global DOA (Drug of Abuse) Readers Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Laboratories
1.3.4 Defense Security
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global DOA (Drug of Abuse) Readers Sales Estimates and Forecasts 2017-2028
2.2 Global DOA (Drug of Abuse) Readers Revenue Estimates and Forecasts 2017-2028
2.3 Global DOA (Drug of Abuse) Readers Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global DOA (Drug of Abuse) Readers Sales by Region
2.4.1 Global DOA (Drug of Abuse) Readers Sales by Region (2017-2022)
2.4.2 Global Sales DOA (Drug of Abuse) Readers by Region (2023-2028)
2.5 Global DOA (Drug of Abuse) Readers Revenue by Region
2.5.1 Global DOA (Drug of Abuse) Readers Revenue by Region (2017-2022)
2.5.2 Global DOA (Drug of Abuse) Readers Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global DOA (Drug of Abuse) Readers Sales by Manufacturers
3.1.1 Global Top DOA (Drug of Abuse) Readers Manufacturers by Sales (2017-2022)
3.1.2 Global DOA (Drug of Abuse) Readers Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of DOA (Drug of Abuse) Readers in 2021
3.2 Global DOA (Drug of Abuse) Readers Revenue by Manufacturers
3.2.1 Global DOA (Drug of Abuse) Readers Revenue by Manufacturers (2017-2022)
3.2.2 Global DOA (Drug of Abuse) Readers Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by DOA (Drug of Abuse) Readers Revenue in 2021
3.3 Global DOA (Drug of Abuse) Readers Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global DOA (Drug of Abuse) Readers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global DOA (Drug of Abuse) Readers Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global DOA (Drug of Abuse) Readers Sales by Type
4.1.1 Global DOA (Drug of Abuse) Readers Historical Sales by Type (2017-2022)
4.1.2 Global DOA (Drug of Abuse) Readers Forecasted Sales by Type (2023-2028)
4.1.3 Global DOA (Drug of Abuse) Readers Sales Market Share by Type (2017-2028)
4.2 Global DOA (Drug of Abuse) Readers Revenue by Type
4.2.1 Global DOA (Drug of Abuse) Readers Historical Revenue by Type (2017-2022)
4.2.2 Global DOA (Drug of Abuse) Readers Forecasted Revenue by Type (2023-2028)
4.2.3 Global DOA (Drug of Abuse) Readers Revenue Market Share by Type (2017-2028)
4.3 Global DOA (Drug of Abuse) Readers Price by Type
4.3.1 Global DOA (Drug of Abuse) Readers Price by Type (2017-2022)
4.3.2 Global DOA (Drug of Abuse) Readers Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global DOA (Drug of Abuse) Readers Sales by Application
5.1.1 Global DOA (Drug of Abuse) Readers Historical Sales by Application (2017-2022)
5.1.2 Global DOA (Drug of Abuse) Readers Forecasted Sales by Application (2023-2028)
5.1.3 Global DOA (Drug of Abuse) Readers Sales Market Share by Application (2017-2028)
5.2 Global DOA (Drug of Abuse) Readers Revenue by Application
5.2.1 Global DOA (Drug of Abuse) Readers Historical Revenue by Application (2017-2022)
5.2.2 Global DOA (Drug of Abuse) Readers Forecasted Revenue by Application (2023-2028)
5.2.3 Global DOA (Drug of Abuse) Readers Revenue Market Share by Application (2017-2028)
5.3 Global DOA (Drug of Abuse) Readers Price by Application
5.3.1 Global DOA (Drug of Abuse) Readers Price by Application (2017-2022)
5.3.2 Global DOA (Drug of Abuse) Readers Price Forecast by Application (2023-2028)
6 North America
6.1 North America DOA (Drug of Abuse) Readers Market Size by Type
6.1.1 North America DOA (Drug of Abuse) Readers Sales by Type (2017-2028)
6.1.2 North America DOA (Drug of Abuse) Readers Revenue by Type (2017-2028)
6.2 North America DOA (Drug of Abuse) Readers Market Size by Application
6.2.1 North America DOA (Drug of Abuse) Readers Sales by Application (2017-2028)
6.2.2 North America DOA (Drug of Abuse) Readers Revenue by Application (2017-2028)
6.3 North America DOA (Drug of Abuse) Readers Market Size by Country
6.3.1 North America DOA (Drug of Abuse) Readers Sales by Country (2017-2028)
6.3.2 North America DOA (Drug of Abuse) Readers Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe DOA (Drug of Abuse) Readers Market Size by Type
7.1.1 Europe DOA (Drug of Abuse) Readers Sales by Type (2017-2028)
7.1.2 Europe DOA (Drug of Abuse) Readers Revenue by Type (2017-2028)
7.2 Europe DOA (Drug of Abuse) Readers Market Size by Application
7.2.1 Europe DOA (Drug of Abuse) Readers Sales by Application (2017-2028)
7.2.2 Europe DOA (Drug of Abuse) Readers Revenue by Application (2017-2028)
7.3 Europe DOA (Drug of Abuse) Readers Market Size by Country
7.3.1 Europe DOA (Drug of Abuse) Readers Sales by Country (2017-2028)
7.3.2 Europe DOA (Drug of Abuse) Readers Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific DOA (Drug of Abuse) Readers Market Size by Type
8.1.1 Asia Pacific DOA (Drug of Abuse) Readers Sales by Type (2017-2028)
8.1.2 Asia Pacific DOA (Drug of Abuse) Readers Revenue by Type (2017-2028)
8.2 Asia Pacific DOA (Drug of Abuse) Readers Market Size by Application
8.2.1 Asia Pacific DOA (Drug of Abuse) Readers Sales by Application (2017-2028)
8.2.2 Asia Pacific DOA (Drug of Abuse) Readers Revenue by Application (2017-2028)
8.3 Asia Pacific DOA (Drug of Abuse) Readers Market Size by Region
8.3.1 Asia Pacific DOA (Drug of Abuse) Readers Sales by Region (2017-2028)
8.3.2 Asia Pacific DOA (Drug of Abuse) Readers Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America DOA (Drug of Abuse) Readers Market Size by Type
9.1.1 Latin America DOA (Drug of Abuse) Readers Sales by Type (2017-2028)
9.1.2 Latin America DOA (Drug of Abuse) Readers Revenue by Type (2017-2028)
9.2 Latin America DOA (Drug of Abuse) Readers Market Size by Application
9.2.1 Latin America DOA (Drug of Abuse) Readers Sales by Application (2017-2028)
9.2.2 Latin America DOA (Drug of Abuse) Readers Revenue by Application (2017-2028)
9.3 Latin America DOA (Drug of Abuse) Readers Market Size by Country
9.3.1 Latin America DOA (Drug of Abuse) Readers Sales by Country (2017-2028)
9.3.2 Latin America DOA (Drug of Abuse) Readers Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa DOA (Drug of Abuse) Readers Market Size by Type
10.1.1 Middle East and Africa DOA (Drug of Abuse) Readers Sales by Type (2017-2028)
10.1.2 Middle East and Africa DOA (Drug of Abuse) Readers Revenue by Type (2017-2028)
10.2 Middle East and Africa DOA (Drug of Abuse) Readers Market Size by Application
10.2.1 Middle East and Africa DOA (Drug of Abuse) Readers Sales by Application (2017-2028)
10.2.2 Middle East and Africa DOA (Drug of Abuse) Readers Revenue by Application (2017-2028)
10.3 Middle East and Africa DOA (Drug of Abuse) Readers Market Size by Country
10.3.1 Middle East and Africa DOA (Drug of Abuse) Readers Sales by Country (2017-2028)
10.3.2 Middle East and Africa DOA (Drug of Abuse) Readers Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Prometheus
11.1.1 Prometheus Corporation Information
11.1.2 Prometheus Overview
11.1.3 Prometheus DOA (Drug of Abuse) Readers Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Prometheus DOA (Drug of Abuse) Readers Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Prometheus Recent Developments
11.2 T-READER
11.2.1 T-READER Corporation Information
11.2.2 T-READER Overview
11.2.3 T-READER DOA (Drug of Abuse) Readers Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 T-READER DOA (Drug of Abuse) Readers Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 T-READER Recent Developments
11.3 DIALAB
11.3.1 DIALAB Corporation Information
11.3.2 DIALAB Overview
11.3.3 DIALAB DOA (Drug of Abuse) Readers Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 DIALAB DOA (Drug of Abuse) Readers Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 DIALAB Recent Developments
11.4 Princeton BioMeditech
11.4.1 Princeton BioMeditech Corporation Information
11.4.2 Princeton BioMeditech Overview
11.4.3 Princeton BioMeditech DOA (Drug of Abuse) Readers Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Princeton BioMeditech DOA (Drug of Abuse) Readers Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Princeton BioMeditech Recent Developments
11.5 Abbott
11.5.1 Abbott Corporation Information
11.5.2 Abbott Overview
11.5.3 Abbott DOA (Drug of Abuse) Readers Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Abbott DOA (Drug of Abuse) Readers Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Abbott Recent Developments
11.6 Zhejiang Orient Gene Biotech
11.6.1 Zhejiang Orient Gene Biotech Corporation Information
11.6.2 Zhejiang Orient Gene Biotech Overview
11.6.3 Zhejiang Orient Gene Biotech DOA (Drug of Abuse) Readers Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Zhejiang Orient Gene Biotech DOA (Drug of Abuse) Readers Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Zhejiang Orient Gene Biotech Recent Developments
11.7 Assure Tech (Hangzhou)
11.7.1 Assure Tech (Hangzhou) Corporation Information
11.7.2 Assure Tech (Hangzhou) Overview
11.7.3 Assure Tech (Hangzhou) DOA (Drug of Abuse) Readers Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Assure Tech (Hangzhou) DOA (Drug of Abuse) Readers Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Assure Tech (Hangzhou) Recent Developments
11.8 Wuhan NanoDiagnosis For Health Biotechnology
11.8.1 Wuhan NanoDiagnosis For Health Biotechnology Corporation Information
11.8.2 Wuhan NanoDiagnosis For Health Biotechnology Overview
11.8.3 Wuhan NanoDiagnosis For Health Biotechnology DOA (Drug of Abuse) Readers Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Wuhan NanoDiagnosis For Health Biotechnology DOA (Drug of Abuse) Readers Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Wuhan NanoDiagnosis For Health Biotechnology Recent Developments
11.9 Simple & Smart Instrument (Nanjing)
11.9.1 Simple & Smart Instrument (Nanjing) Corporation Information
11.9.2 Simple & Smart Instrument (Nanjing) Overview
11.9.3 Simple & Smart Instrument (Nanjing) DOA (Drug of Abuse) Readers Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Simple & Smart Instrument (Nanjing) DOA (Drug of Abuse) Readers Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Simple & Smart Instrument (Nanjing) Recent Developments
11.10 Xuzhou Anding Biotechnology
11.10.1 Xuzhou Anding Biotechnology Corporation Information
11.10.2 Xuzhou Anding Biotechnology Overview
11.10.3 Xuzhou Anding Biotechnology DOA (Drug of Abuse) Readers Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Xuzhou Anding Biotechnology DOA (Drug of Abuse) Readers Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Xuzhou Anding Biotechnology Recent Developments
11.11 Guangdong Jindun Electronic Technology
11.11.1 Guangdong Jindun Electronic Technology Corporation Information
11.11.2 Guangdong Jindun Electronic Technology Overview
11.11.3 Guangdong Jindun Electronic Technology DOA (Drug of Abuse) Readers Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Guangdong Jindun Electronic Technology DOA (Drug of Abuse) Readers Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Guangdong Jindun Electronic Technology Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 DOA (Drug of Abuse) Readers Industry Chain Analysis
12.2 DOA (Drug of Abuse) Readers Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 DOA (Drug of Abuse) Readers Production Mode & Process
12.4 DOA (Drug of Abuse) Readers Sales and Marketing
12.4.1 DOA (Drug of Abuse) Readers Sales Channels
12.4.2 DOA (Drug of Abuse) Readers Distributors
12.5 DOA (Drug of Abuse) Readers Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 DOA (Drug of Abuse) Readers Industry Trends
13.2 DOA (Drug of Abuse) Readers Market Drivers
13.3 DOA (Drug of Abuse) Readers Market Challenges
13.4 DOA (Drug of Abuse) Readers Market Restraints
14 Key Findings in The Global DOA (Drug of Abuse) Readers Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer